Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
21 Nov 2016
Energy Drinks Associated with Hepatitis
ENERGY DRINKS have been associated with liver damage in a new case report authored by Dr Jennifer Harb, Department of Dermatology, University of…
3
Mins
15 Nov 2016
Epstein-Barr Virus: Cholestasis, Hepatitis, Or Both?
Epstein-Barr Virus (EBV), or more commonly known as the ‘kissing disease’ is seemingly unavoidable within the adolescent and teenage community.
5 Sep 2016
The International Liver Cancer Association’s (ILCA) 10th ILCA Annual Conference
Canada, September 9-11, 2016 – We also take this opportunity to personally invite you to attend the 10th ILCA Annual Conference.
30 Aug 2016
CDK4 Protein Both a Trigger and Target for Treatment of Liver Disease
SCIENTISTS have identified the CDK4 protein as a trigger for the development of non-alcoholic fatty liver disease (NAFLD) and found that its inhibition…
30 Aug 2016
Burden of Viral Hepatitis Grows
KILLING as many people as tuberculosis, HIV/AIDS, or malaria, hepatitis has risen in worldwide prominence, resulting annually in 1.45 million deaths.
23 Aug 2016
Cirrhosis: Reviewing the Literature and Future Perspectives
Cirrhosis is the final stage of chronic liver disease and has many causes, including viral hepatitis, excessive alcohol intake, and non-alcoholic…
23 Aug 2016
Hepatitis C: Is Regression of Advanced Fibrosis Possible After Treatment?
Liver cirrhosis represents a severe complication for hepatitis C patients. Patients with cirrhosis require immediate treatment; a sustained virological…
3 Aug 2016
New Report Calls for Universal Vaccination for Hepatitis to Reduce the Crippling Economic Burden of the Disease
Vienna, July 28, 2016 – To coincide with World Hepatitis Day, a new report1, commissioned by United European Gastroenterology (UEG), calls for all…
Loading posts...
« Previous
1
…
64
65
66
67
68
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View